Schedule 13G ownership disclosure

Sionna Therapeutics Inc

Common Stock, $0.001 par value per share · CUSIP: 829401108

Event date: 2025-09-30

Filing-level shares
1,980,626.0
Percent of class
4.4%
  • JPMORGAN CHASE & CO.

    Shares: 1,980,626.0 · Class: 4.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000019617-25-001066
Form type
SCHEDULE 13G/A
Filer
JPMORGAN CHASE & CO
CIK
CIK 19617
Filed
Oct 31, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub